Status:
RECRUITING
Effect of Sarcopenia on Clinical Outcome of Total Knee Arthroplasty
Lead Sponsor:
Gangnam Severance Hospital
Conditions:
Knee Osteoarthritis
Eligibility:
FEMALE
60+ years
Phase:
NA
Brief Summary
As human life expectancy increases, the prevalence of degenerative osteoarthritis of the knee joints is steadily rising, leading to a significant surge in the frequency of total knee arthroplasty (TKA...
Eligibility Criteria
Inclusion
- A woman aged 60 or older who is undergoing TKA due to degenerative osteoarthritis of the knee joint at the our institution.
Exclusion
- Male
- Under 60 years of age
- Patients with a history of rheumatoid arthritis, traumatic joint disease, and post-infection joint disease
- Patients who cannot undergo tests for muscle weakness diagnosis A. Patients unable to walk B. Patients unable to stand alone due to conditions like cerebral palsy or brain disorders C. Patients unable to use muscle strength
- Patients considered inappropriate for recruitment in this study based on the judgment of the research team.
Key Trial Info
Start Date :
June 3 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06136039
Start Date
June 3 2022
End Date
December 31 2024
Last Update
July 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
GangnamSeverance Hospital
Seoul, South Korea